IL106953A0 - Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions - Google Patents

Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions

Info

Publication number
IL106953A0
IL106953A0 IL106953A IL10695393A IL106953A0 IL 106953 A0 IL106953 A0 IL 106953A0 IL 106953 A IL106953 A IL 106953A IL 10695393 A IL10695393 A IL 10695393A IL 106953 A0 IL106953 A0 IL 106953A0
Authority
IL
Israel
Prior art keywords
adsorbate
preparation
pharmaceutical compositions
active compound
solid active
Prior art date
Application number
IL106953A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL106953A0 publication Critical patent/IL106953A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL106953A 1992-09-11 1993-09-09 Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions IL106953A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4230371 1992-09-11

Publications (1)

Publication Number Publication Date
IL106953A0 true IL106953A0 (en) 1993-12-28

Family

ID=6467712

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106953A IL106953A0 (en) 1992-09-11 1993-09-09 Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions

Country Status (13)

Country Link
EP (1) EP0587137A1 (index.php)
JP (1) JPH06192093A (index.php)
KR (1) KR940006583A (index.php)
AU (1) AU663000B2 (index.php)
CA (1) CA2105913A1 (index.php)
FI (1) FI933954L (index.php)
HU (1) HUT67577A (index.php)
IL (1) IL106953A0 (index.php)
MX (1) MX9305578A (index.php)
NO (1) NO933237L (index.php)
NZ (1) NZ248627A (index.php)
TW (1) TW222585B (index.php)
ZA (1) ZA936695B (index.php)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ267002A (en) * 1993-06-04 1997-07-27 Warner Lambert Co Chewable cold/sinus relief preparation comprising antihistamine and decongestant in a carrier consisting of silicon dioxide
US5626878A (en) * 1995-01-10 1997-05-06 Warner Lambert Company Reduction of electrostatic forces between magnesium trisilicate adsorbates
BR9916361A (pt) * 1998-12-18 2002-11-05 Abbott Lab Forma de dosagem de tabletes de liberação controlada, formulação de tablete de liberação controlada, composição granular para prensagem em uma forma de dosagem de tablete de liberação controlada, e, métodos para preparar uma composição granular, para preparar uma forma de dosagem de tabletes de liberação controlada de divalproex sódio e para tratar epilepsia
EP1765297A2 (en) * 2004-06-28 2007-03-28 LifeCycle Pharma A/S Porous tablets as carriers for liquid formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879161A (en) * 1956-05-14 1959-03-24 American Cyanamid Co Stable dry powder compositions containing choline chloride and methods of preparing same
DE3409063A1 (de) * 1984-03-13 1985-09-19 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von fliessfaehigen cholinchlorid-kieselsaeure-pulvern
DE3924093A1 (de) * 1989-07-20 1991-02-07 Hoechst Ag N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE4020570A1 (de) * 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms

Also Published As

Publication number Publication date
EP0587137A1 (de) 1994-03-16
NO933237D0 (no) 1993-09-10
HU9302555D0 (en) 1993-11-29
FI933954A7 (fi) 1994-03-12
TW222585B (index.php) 1994-04-21
MX9305578A (es) 1994-03-31
NO933237L (no) 1994-03-14
KR940006583A (ko) 1994-04-25
FI933954L (fi) 1994-03-12
AU4626293A (en) 1994-03-17
JPH06192093A (ja) 1994-07-12
HUT67577A (en) 1995-04-28
AU663000B2 (en) 1995-09-21
FI933954A0 (fi) 1993-09-09
ZA936695B (en) 1994-04-05
NZ248627A (en) 1995-01-27
CA2105913A1 (en) 1994-03-12

Similar Documents

Publication Publication Date Title
GB2143734B (en) Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content
IL113818A0 (en) Pharmaceutical active cns compounds and pharmaceutical compositions containing them
IL107978A0 (en) Mannitol derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
CZ8193A3 (en) Pharmaceutical dosing form with prolonged release of active compound
HUT72985A (en) Stabilized medicinal aerosol solution formulations
IL107771A0 (en) Pharmaceutical compositions containing isothiourea derivatives certain such novel compounds and their preparation
HUT49625A (en) Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient
ZA934090B (en) Biphenyl derivatives pharmaceutical compositions containing these compounds and processes for preparing them
IL108019A0 (en) Hydroxyiminoalkylindole-carboxylic acid derivatives their preparation and pharmaceutical compositions containing them
EP0440809A4 (en) Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient
SG43083A1 (en) Benzinidaziles pharmaceutical compositions containing these compounds and processes for preparing them
AU4480889A (en) A pharmaceutical composition for rapid release of the active component comprising an orderred mixture and a surfactant
IL105406A (en) Derivatives of adipogenesis inhibitory factor processes for the preparation thereof and pharmaceutical compositions containing the same
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
IL107611A0 (en) Steroid compounds and pharmaceutical compositions containing them
IL106953A0 (en) Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions
IL102116A (en) Hetaryloxy-beta-carboline derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
ZA933638B (en) Heterocyclic compounds a process for the preparation thereof and pharmaceutical compositions containing them
AU4532893A (en) Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
ZA939195B (en) Stabilized medicinal aerosol solution formulations
HRP940315B1 (en) Process for the preparation of pharmaceutical compositions containinbg active ingredient
AP9300542A0 (en) 17a and 17b-alkylketone-3-carboxyaromatic a ring steroidal compounds and pharmaceutical compositions containing these compounds
EP0106335A3 (en) Pharmaceutical composition and a method for enhancing the absorption of a pharmaceutically active compound
ZA94368B (en) Amino acid derivatives pharmaceutical compositions containing these compound and processes for their preparation
GB9203265D0 (en) Pharmaceutically active compound